This Week in Peptides: FDA Sends Peptide Policy to the White House
The FDA sent an interim peptide compounding policy to White House review on Oct 14, 2026. It may let pharmacies make some peptides like BPC-157. It is not final.
Weekly FDA and science updates, in plain English. Also see the FDA warning letters tracker.
The FDA sent an interim peptide compounding policy to White House review on Oct 14, 2026. It may let pharmacies make some peptides like BPC-157. It is not final.